MedKoo Cat#: 598054 | Name: Diacetylsplenopentin HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Diacetylsplenopentin HCl is a synthetic immunomodulator that affects the proliferation and differentiation of bone marrow stem cells without stimulating pathological immune responses beyond the balance of the immune system. This effect is specifically studied on leukocytes.

Chemical Structure

Diacetylsplenopentin HCl
CAS#122402-38-4

Theoretical Analysis

MedKoo Cat#: 598054

Name: Diacetylsplenopentin HCl

CAS#: 122402-38-4

Chemical Formula: C35H56ClN9O11

Exact Mass: 813.3788

Molecular Weight: 814.33

Elemental Analysis: C, 51.62; H, 6.93; Cl, 4.35; N, 15.48; O, 21.61

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Diacetylsplenopentin hydrochloride; Diacetylsplenopentin HCl;
IUPAC/Chemical Name
(6S,9S,12S,15S,18S)-6-acetamido-9-(4-acetamidobutyl)-1-amino-12-(2-carboxyethyl)-18-(4-hydroxybenzyl)-1-imino-15-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecan-19-oic acid hydrochloride
InChi Key
MAZFTYVMQDNCCO-WRRQFKQISA-N
InChi Code
InChI=1S/C35H55N9O11.ClH/c1-19(2)29(33(53)43-27(34(54)55)18-22-10-12-23(47)13-11-22)44-32(52)26(14-15-28(48)49)42-31(51)25(8-5-6-16-38-20(3)45)41-30(50)24(40-21(4)46)9-7-17-39-35(36)37;/h10-13,19,24-27,29,47H,5-9,14-18H2,1-4H3,(H,38,45)(H,40,46)(H,41,50)(H,42,51)(H,43,53)(H,44,52)(H,48,49)(H,54,55)(H4,36,37,39);1H/t24-,25-,26-,27-,29-;/m0./s1
SMILES Code
OC1=CC=C(C=C1)C[C@@H](C(O)=O)NC([C@H](C(C)C)NC([C@H](CCC(O)=O)NC([C@H](CCCCNC(C)=O)NC([C@H](CCCNC(N)=N)NC(C)=O)=O)=O)=O)=O.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 814.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Liebermann HT, Thalmann G, Bartels T, Nöckler A. Experiments on an early protection against foot-and-mouth disease virus. Acta Virol. 1993 Apr-Jun;37(2-3):181-3. PubMed PMID: 8105663. 2: Bräuer R, Thoss K, Henzgen S, Waldmann G. Effects of the immunomodulator diacetyl-splenopentin on antigen-induced arthritis in rabbits. Agents Actions. 1992 Jan;35(1-2):96-103. PubMed PMID: 1387284. 3: Simon HU, Lauterbach H, Börner A, Wachtel S. Diacetyl-splenopentin (BCH 069) did not affect the concentrations of various hormones in men. Exp Clin Endocrinol. 1990 Dec;96(3):314-6. PubMed PMID: 2083571. 4: Simon HU, Metzner G, Vogt WE, Piesch C, Forner K, Schlenvoigt G, Storz H, Haroske D, Jäger L. Clinical, biochemical and immunological effectiveness of diacetyl-splenopentin (BCH 069) in hay fever. Allergol Immunopathol (Madr). 1990 May-Jun;18(3):155-60. PubMed PMID: 2251976. 5: Simon HU, Kraul H, Schäfer R, Kilian U, Hoffmann A. Lack of effect of diacetyl-splenopentin (Berlopentin) on the pharmacokinetics of caffeine. Pharmazie. 1992 Jan;47(1):49-50. PubMed PMID: 1608985. 6: Simon HU, Reipert B, Haroske D, Forner K, Storz H. [Age-dependent sensitivity of human lymphocytes to the immunomodulating effect of bovine and human diacetyl splenopentin]. Allerg Immunol (Leipz). 1990;36(4):351-8. German. PubMed PMID: 2151503. 7: Baumgart J, Zippel D. Age-dependent experimental tumor dissemination of murine melanoma B16. Arch Immunol Ther Exp (Warsz). 1991;39(5-6):489-94. PubMed PMID: 1841547. 8: Simon HU, Forner K, Büttner A, Haroske D, Vogt KH. [The lymphocyte transformation test using mononuclear cells of elderly humans as a suitable in vitro method for testing of structure activity relationships of splenin peptides]. Pharmazie. 1990 Dec;45(12):917-9. German. PubMed PMID: 2100799. 9: Simon HU, Metzner G, Keil E, Forner K, Vogt WE, Jäger L. Phase-I study of diacetyl-splenopentin (BCH 069). Allerg Immunol (Leipz). 1990;36(4):245-51. PubMed PMID: 1982983.